Skip to main content
. 2018 Sep 24;53(Suppl 1):19–144. doi: 10.1038/s41409-018-0318-y
Outcomes Hazard Ratio 3-year Probability
Non-relapse mortality
 Matched URD HCT 1.00 25% (95% CI 21–29)
 Haploidentical HCT 1.02 (95% CI 0.70–1.48) p = 0.92 22% (95% CI 15–29)
Relapse
 Matched URD HCT 1.00 40% (95% CI 35–44)
 Haploidentical HCT 0.99 (95% CI 0.72–1.37) p = 0.95 41% (95% CI 33–49)
Survival
 Matched URD HCT 1.00 47% (95% CI 42–51)
 Haploidentical HCT 1.27 (95% CI 1.01–1.59) p = 0.04 43% (95% CI 34–51)